Project: Gyroplexed Nucleosomic® biomarker panels for lung cancer screening

Acronym GyroNuQ (Reference Number: 113485)
Duration 01/10/2019 - 03/04/2022
Project Topic We propose the development of a triaging test for Low Dose Computed Tomography positive individuals using simple, low cost Nu.Q™ immunoassay profiling of circulating, cell free nucleosomes on a multi-parallel, high throughput platform - Gyroplex™. Deliverables include: 12 Gyro-Nu.Q™ Research Use assays in high sensitivity Gyroplex™ format; Nu.Q™ profiles to differentiate lung cancer from benign disease; Validated Triage panel in a prospectively collected cohort ready for regulatory trials.
Network Eurostars 2
Call Eurostars Cut–off 11

Project partner

Number Name Role Country
1 Belgian Volition SPRL Coordinator Belgium
2 Gyros Protein Technologies AB Partner Sweden